Jefferies Group LLC Amicus Therapeutics, Inc. Call Options Transaction History

Jefferies Group LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $222,105 - $273,360	-25,500 Closed	0 $0
Q1 2021 Sep 21, 2023	SELL	$9.2 - $23.86 $184,000 - $477,200	-20,000 Reduced 43.96%	25,500 $251,000
Q1 2021 May 14, 2021	SELL	$9.2 - $23.86 $184,000 - $477,200	-20,000 Reduced 43.96%	25,500 $252,000
Q4 2020 Sep 21, 2023	BUY	$13.47 - $24.89 $612,885 - $1.13 Million	45,500 New	45,500 $1.05 Million
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $269,400 - $497,800	20,000 Added 78.43%	45,500 $1.05 Million
Q3 2020 Nov 13, 2020	BUY	$12.89 - $15.89 $328,695 - $405,195	25,500 New	25,500 $360,000
Q3 2018 Nov 14, 2018	SELL	$11.6 - $16.54 $15,080 - $21,502	-1,300 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.13 - $17.09 $17,069 - $22,217	1,300 New	1,300 $20,000

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.